| （単位：十億ドル） | 1Q21 | 2Q21 | 3Q21 | 1Q22 | 2Q22 | 3Q22 | 1Q23 | 2Q23 | 3Q23 | 1Q24 | 2Q24 | 3Q24 | 1Q25 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 売上高 | 0 | - | - | - | - | - | - | - | - | - | - | - | - |
| 研究開発費 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 営業費用 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 営業利益 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 |
| 営業利益率 (%) | - | - | - | - | - | - | - | - | - | - | - | - | |
| 経常（税引前）利益 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 |
| 経常（税引前）利益率（％） | -Infinity | - | - | - | - | - | - | - | - | - | - | - | - |
| 法人税等合計 | 0 | - | - | - | - | - | - | - | - | - | - | - | - |
| 実効税率（％） | - | - | - | - | - | - | - | - | - | - | - | - | |
| 純利益 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 |
| 純利益率（％） | - | - | - | - | - | - | - | - | - | - | - | - | |
| 一株あたり利益 | - | - | - | - | - | - | - | - | - | -1.98 | -0.86 | -0.5 | -3.86 |
| 希薄化後一株あたり利益 | - | - | - | - | - | - | - | - | - | -1.98 | -0.86 | -0.5 | -3.86 |
| EBITDA | - | - | - | - | - | - | - | - | |||||
| EBITDAマージン（％） | - | - | - | - | - | - | - | - | - | - | - | - |